Briefing with Invetech - Now it's getting serious assured pathways to commercial manufacturing
Now it’s getting serious - assured pathways to commercial manufacturing.
Today’s pathfinders discuss their vision for the coming era of industrialized cell therapy production
- David Hodl, Vice President, Business Development for Cell Therapy
- Vijay Chiruvolu, VP of Global Process Development - Cell Therapy, Kite Pharma - A Gilead Sciences Company
- Randy Schweickart, Director of Engineering, Juno Therapeutics, Inc.
- Steve Goodman, Head of Drug Product Manufacturing, bluebird bio